Aligned Genetics, Inc. (KOSDAQ: 238120)
South Korea
· Delayed Price · Currency is KRW 2,990.00
-10.00 (-0.33%)
Oct 14, 2024, 10:16 AM KST
Aligned Genetics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 3,315 | 3,236 | 2,333 | 5,542 | 468.23 | 116.74 | Upgrade
|
| Depreciation & Amortization | 610.37 | 631.38 | 650.38 | 538.59 | 676.07 | 716.36 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.5 | -4.5 | - | -13.94 | - | -48.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | -34.04 | -34.04 | 591.23 | -1,686 | -944.36 | -417.33 | Upgrade
|
| Loss (Gain) on Equity Investments | 90.84 | 181.79 | -80.52 | 178.96 | 79.28 | 67.95 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.23 | -0.55 | -11.88 | 2.97 | 20.04 | -7.86 | Upgrade
|
| Other Operating Activities | 397.29 | 487.38 | 417.53 | 99.1 | 683.89 | 340.57 | Upgrade
|
| Change in Accounts Receivable | -456.25 | -1,214 | 717.6 | -2,025 | -371.67 | 186.32 | Upgrade
|
| Change in Inventory | -441.29 | -55.66 | -1,407 | -337.39 | -101.87 | -118.35 | Upgrade
|
| Change in Accounts Payable | -123.28 | 14.31 | -53.19 | 1,017 | 161.57 | 65.71 | Upgrade
|
| Change in Unearned Revenue | - | 9.86 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -993.45 | -452.6 | -1,084 | -1,409 | -635.5 | -241.88 | Upgrade
|
| Operating Cash Flow | 2,464 | 2,849 | 2,222 | 135.97 | 35.67 | 659.29 | Upgrade
|
| Operating Cash Flow Growth | -10.68% | 28.18% | 1534.52% | 281.17% | -94.59% | - | Upgrade
|
| Capital Expenditures | -409.3 | -878.54 | -2,001 | -3,307 | -96.43 | -261.62 | Upgrade
|
| Sale of Property, Plant & Equipment | 12.98 | 12.98 | - | 32.25 | - | 44.94 | Upgrade
|
| Sale (Purchase) of Intangibles | -8.77 | -1.87 | -2.23 | - | -9.07 | -21.69 | Upgrade
|
| Investment in Securities | -2,581 | 1,502 | 4,000 | 248.18 | 699.95 | 1,686 | Upgrade
|
| Other Investing Activities | 377.17 | 655.49 | 555.69 | 916.01 | 571.46 | 86.73 | Upgrade
|
| Investing Cash Flow | -2,602 | 1,290 | 2,537 | -3,668 | 1,166 | 1,534 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 978 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 3,900 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 4,878 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -978 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -192.75 | -176.33 | -267.41 | -227.56 | -203.84 | Upgrade
|
| Total Debt Repaid | -197.01 | -192.75 | -176.33 | -1,245 | -227.56 | -203.84 | Upgrade
|
| Net Debt Issued (Repaid) | -197.01 | -192.75 | -176.33 | 3,633 | -227.56 | -203.84 | Upgrade
|
| Financing Cash Flow | -197.01 | -192.75 | -176.33 | 3,633 | -227.56 | -203.84 | Upgrade
|
| Foreign Exchange Rate Adjustments | 702.98 | 284.86 | -24.31 | 397.42 | -233.22 | 42.15 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 | 0 | - | Upgrade
|
| Net Cash Flow | 368.44 | 4,231 | 4,559 | 498.31 | 740.79 | 2,032 | Upgrade
|
| Free Cash Flow | 2,055 | 1,970 | 220.98 | -3,171 | -60.76 | 397.66 | Upgrade
|
| Free Cash Flow Growth | 420.97% | 791.50% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 13.76% | 12.95% | 1.61% | -26.96% | -0.76% | 5.10% | Upgrade
|
| Free Cash Flow Per Share | 142.91 | 137.01 | 15.37 | -220.57 | -5.84 | 27.66 | Upgrade
|
| Cash Interest Paid | 187.99 | 190.05 | 165.3 | 28.88 | 82.9 | 96.84 | Upgrade
|
| Cash Income Tax Paid | 187.77 | 169 | 49.25 | 113.39 | 8.65 | -18.99 | Upgrade
|
| Levered Free Cash Flow | 738.02 | 947.12 | -388.58 | -2,676 | 345.83 | 222.35 | Upgrade
|
| Unlevered Free Cash Flow | 873.56 | 1,081 | -284.86 | -2,658 | 397.6 | 282.88 | Upgrade
|
| Change in Net Working Capital | 1,106 | 755.22 | 712.21 | 1,251 | 14.54 | -99.16 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.